374 related articles for article (PubMed ID: 16741577)
1. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
Rittershaus PC; Kechichian TB; Allegood JC; Merrill AH; Hennig M; Luberto C; Del Poeta M
J Clin Invest; 2006 Jun; 116(6):1651-9. PubMed ID: 16741577
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal virulence: beyond the usual suspects.
Mitchell AP
J Clin Invest; 2006 Jun; 116(6):1481-3. PubMed ID: 16741574
[TBL] [Abstract][Full Text] [Related]
3. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans.
Petzold EW; Himmelreich U; Mylonakis E; Rude T; Toffaletti D; Cox GM; Miller JL; Perfect JR
Infect Immun; 2006 Oct; 74(10):5877-87. PubMed ID: 16988267
[TBL] [Abstract][Full Text] [Related]
4. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.
Kechichian TB; Shea J; Del Poeta M
Infect Immun; 2007 Oct; 75(10):4792-8. PubMed ID: 17664261
[TBL] [Abstract][Full Text] [Related]
5. The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.
Reuwsaat JCV; Agustinho DP; Motta H; Chang AL; Brown H; Brent MR; Kmetzsch L; Doering TL
mBio; 2021 Mar; 12(2):. PubMed ID: 33688010
[No Abstract] [Full Text] [Related]
6. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.
Singh A; Wang H; Silva LC; Na C; Prieto M; Futerman AH; Luberto C; Del Poeta M
Cell Microbiol; 2012 Apr; 14(4):500-16. PubMed ID: 22151739
[TBL] [Abstract][Full Text] [Related]
7. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system.
Shea JM; Kechichian TB; Luberto C; Del Poeta M
Infect Immun; 2006 Oct; 74(10):5977-88. PubMed ID: 16988277
[TBL] [Abstract][Full Text] [Related]
8. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice.
Waterman SR; Hacham M; Panepinto J; Hu G; Shin S; Williamson PR
Infect Immun; 2007 Feb; 75(2):714-22. PubMed ID: 17101662
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis.
Upadhya R; Baker LG; Lam WC; Specht CA; Donlin MJ; Lodge JK
mBio; 2018 Nov; 9(6):. PubMed ID: 30459196
[TBL] [Abstract][Full Text] [Related]
10. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease.
Vu K; Tham R; Uhrig JP; Thompson GR; Na Pombejra S; Jamklang M; Bautos JM; Gelli A
mBio; 2014 Jun; 5(3):e01101-14. PubMed ID: 24895304
[TBL] [Abstract][Full Text] [Related]
11.
Goughenour K; Creech A; Xu J; He X; Hissong R; Giamberardino C; Tenor J; Toffaletti D; Perfect J; Olszewski M
Front Cell Infect Microbiol; 2024; 14():1392015. PubMed ID: 38841113
[TBL] [Abstract][Full Text] [Related]
12. The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans.
Munshi MA; Gardin JM; Singh A; Luberto C; Rieger R; Bouklas T; Fries BC; Del Poeta M
Cell Rep; 2018 Feb; 22(6):1392-1400. PubMed ID: 29425496
[TBL] [Abstract][Full Text] [Related]
13. Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.
García-Rodas R; Cordero RJ; Trevijano-Contador N; Janbon G; Moyrand F; Casadevall A; Zaragoza O
mBio; 2014 Jun; 5(3):e00945-14. PubMed ID: 24939886
[TBL] [Abstract][Full Text] [Related]
14. The Monothiol Glutaredoxin Grx4 Regulates Iron Homeostasis and Virulence in Cryptococcus neoformans.
Attarian R; Hu G; Sánchez-León E; Caza M; Croll D; Do E; Bach H; Missall T; Lodge J; Jung WH; Kronstad JW
mBio; 2018 Dec; 9(6):. PubMed ID: 30514787
[TBL] [Abstract][Full Text] [Related]
15. Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.
Raj S; Nazemidashtarjandi S; Kim J; Joffe L; Zhang X; Singh A; Mor V; Desmarini D; Djordjevic J; Raleigh DP; Rodrigues ML; London E; Del Poeta M; Farnoud AM
Biochim Biophys Acta Biomembr; 2017 Nov; 1859(11):2224-2233. PubMed ID: 28865794
[TBL] [Abstract][Full Text] [Related]
16. Aspartyl peptidase May1 induces host inflammatory response by altering cell wall composition in the fungal pathogen
Li Y; Chadwick B; Pham T; Xie X; Lin X
mBio; 2024 Jun; 15(6):e0092024. PubMed ID: 38742885
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.
Wormley FL; Heinrich G; Miller JL; Perfect JR; Cox GM
Infect Immun; 2005 Aug; 73(8):5022-30. PubMed ID: 16041017
[TBL] [Abstract][Full Text] [Related]
18. Regulation of virulence factors, carbon utilization and virulence by SNF1 in Cryptococcus neoformans JEC21 and divergent actions of SNF1 between cryptococcal strains.
Yang J; Li D; Liu X; Pan J; Yan B; Zhu X
Fungal Genet Biol; 2010 Dec; 47(12):994-1000. PubMed ID: 20719250
[TBL] [Abstract][Full Text] [Related]
19. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.
Luberto C; Martinez-Mariño B; Taraskiewicz D; Bolaños B; Chitano P; Toffaletti DL; Cox GM; Perfect JR; Hannun YA; Balish E; Del Poeta M
J Clin Invest; 2003 Oct; 112(7):1080-94. PubMed ID: 14523045
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
